Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy.
Lang
G D
GD
Dougall
A
A
D000328:Adult; D000464:Alginates / Q000627:therapeutic use*; D000536:Aluminum Hydroxide / Q000627:therapeutic use*; D000863:Antacids / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use*; D002254:Carbonates / Q000627:therapeutic use*; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D017633:Magnesium Silicates; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012824:Silicic Acid / Q000627:therapeutic use*; D012822:Silicon Dioxide / Q000627:therapeutic use*
D000464:Alginates; D000863:Antacids; D001639:Bicarbonates; D002254:Carbonates; D017633:Magnesium Silicates; C060497:Algicon; D012824:Silicic Acid; D000536:Aluminum Hydroxide; D012822:Silicon Dioxide; C001671:magnesium trisilicate; D008274:Magnesium